Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The Peru tuberculosis diagnostics market was valued at USD 385.87 Million in 2025 and is expected to grow at a CAGR of 4.90%, reaching USD 622.58 Million by 2035. The market growth is driven by the decentralization of molecular diagnostic infrastructure, government investments in tuberculosis control programmes, international funding for laboratory modernization, integration of AI-assisted chest X-ray screening, expansion of rapid drug-susceptibility testing, and improved access to diagnostic services across primary healthcare facilities and underserved populations.

Key Market Trends and Insights

  • By diagnostics, molecular diagnostics are likely to lead in the forecast period.
  • By disease type, latent tuberculosis diagnostics are anticipated to hold nearly 40% of the market in the forecast period.
  • By end user, the diagnostic labs segment led the market in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 385.87 Million
  • Projected Market Size (2035): USD 622.58 Million
  • CAGR (2026-2035): 4.90%

Compound Annual Growth Rate

4.9%

Value in USD Million

2026-2035


Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Peru Tuberculosis Diagnostics Market Overview

Tuberculosis (TB) diagnosis refers to the clinical and laboratory procedures used to detect infection with Mycobacterium tuberculosis, the bacterium responsible for tuberculosis. It involves identifying the presence of the pathogen, determining whether the infection is active or latent, and assessing whether the bacterial strain is resistant to commonly used anti-TB drugs. The market was valued at USD 385.87 Million in 2025, driven by the high national burden of tuberculosis, increasing incidence of drug-resistant TB, government-led expansion of molecular diagnostic infrastructure, and rising adoption of rapid and decentralized testing technologies.

Peru Tuberculosis Diagnostics Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

Expansion of decentralized molecular testing and drug-resistance detection

In April 2026, MINSA reported conducting over 100,000 rapid molecular tests using GeneXpert and Truenat technologies.

Market Restraints

Uneven diagnostic access and recurring infrastructure costs

Limited testing facilities, specimen transportation, trained personnel, consumables, and maintenance constrain reliable diagnostic services in remote communities.

Market Opportunities

Adoption of AI-enabled imaging and molecular diagnostic technologies

In February 2025, Peru's Ministry of Health delivered 28 AI-enabled X-ray machines and 33 TRUELAB molecular diagnostic devices with Global Fund financing.

Peru Tuberculosis Diagnostics Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Peru Tuberculosis Diagnostics Market Growth Drivers

Expansion of Decentralized Molecular Testing and Drug-Resistance Detection to Enhance the Market Value

The expansion of rapid molecular tuberculosis diagnostics is strengthening early detection and improving access to drug-resistance testing, particularly in underserved communities. In April 2026, the Ministry of Health (MINSA) reported processing more than 100,000 rapid molecular tests using GeneXpert and Truenat technologies. Additionally, on September 16, 2026, the Global Fund confirmed Peru’s participation in an initiative to deploy nearly 3 million portable molecular TB tests across 13 countries by the end of 2026. These initiatives support decentralized diagnostics and create opportunities for market expansion.

Peru Tuberculosis Diagnostics Market Restraints

Uneven Diagnostic Access and Last-Mile Infrastructure Market Constraints

The most important market restraint is the uneven distribution of molecular diagnostic capacity and inadequate specimen-transport infrastructure, which limit effective utilization of testing platforms outside established healthcare networks. Although decentralization is progressing, equipment availability alone does not ensure reliable testing volumes: trained personnel, consumables, maintenance, specimen logistics, and referral coordination must also be sustained. From a healthcare-financing perspective, these recurrent operating costs compete with other public-health priorities, potentially delaying procurement and limiting returns on diagnostic infrastructure investments, particularly in geographically dispersed and resource-constrained communities.

Peru Tuberculosis Diagnostics Market Opportunities

Expansion of AI-Enabled and Molecular Diagnostic Technologies to Boost the Market Growth

The adoption of advanced diagnostic technologies is creating opportunities for Peru's tuberculosis diagnostics market by improving early detection and expanding access to testing. In February 2025, Peru's Ministry of Health, with Global Fund financing, delivered 28 AI-enabled X-ray machines and 33 TRUELAB molecular diagnostic devices to healthcare facilities. These technologies support active case finding and rapid confirmation of TB, strengthening decentralized diagnostic capabilities and improving access to timely testing.

Peru Tuberculosis Diagnostics Market Trends

The market is witnessing several key trends, including the expansion of decentralized testing, the adoption of advanced molecular technologies, and the integration of artificial intelligence (AI) into screening programs.

Integration of AI-Assisted Screening with Portable Molecular Diagnostics to Elevate the Market Demand

The Peru tuberculosis diagnostics market is increasingly characterized by decentralized molecular testing and AI-enabled imaging to strengthen case detection, particularly in remote and underserved areas. In October 2026, Agencia Andina reported that Peru’s Ministry of Health distributed 67 portable MiniDock devices, which can diagnose tuberculosis in about 25 minutes, while expanding its national network of AI-enabled digital X-ray units to 70. These initiatives support faster screening and access to confirmatory diagnostics.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Peru Tuberculosis Diagnostics Market Share

Latent Tuberculosis Diagnostics to Maintain a Leading Market Position by Disease Type

The market is segmented by disease type into pulmonary tuberculosis diagnostics, extrapulmonary tuberculosis diagnostics, and latent tuberculosis infection diagnostics. Among these, the latent tuberculosis diagnostics segment is expected to maintain a leading position, supported by the need to identify tuberculosis infections before symptoms develop and prevent their progression to active disease. The growing emphasis on early detection and preventive treatment is likely to strengthen demand for latent tuberculosis testing. This focus on identifying and managing latent infections is expected to support the segment’s continued contribution to the market.

Leading Players in the Peru Tuberculosis Diagnostics Market

The key features of the market report include strategic initiatives by leading players. The major companies in the market are as follows:

Qiagen N.V.

Qiagen develops molecular diagnostic technologies and sample preparation solutions, supporting tuberculosis detection and drug-resistance testing through its nucleic acid extraction and amplification platforms. Its product portfolio includes QuantiFERON-TB Gold Plus for latent tuberculosis infection testing and specialized molecular assays. The company serves clinical laboratories, hospitals and research institutions across international healthcare markets.

FUJIFILM Holdings Corporation

FUJIFILM operates across healthcare, medical imaging and diagnostic technologies, offering solutions for tuberculosis screening and disease detection. Its portfolio includes digital radiography systems, medical imaging equipment and AI-assisted diagnostic technologies. The company leverages its global distribution network and imaging expertise to support healthcare infrastructure, particularly in emerging markets and resource-constrained diagnostic settings.

Molbio Diagnostics Private Limited

Molbio Diagnostics specializes in portable molecular diagnostic technologies, particularly its Truenat platform, which enables decentralized tuberculosis testing. Its solutions support the detection of Mycobacterium tuberculosis and rifampicin resistance through rapid, chip-based real-time PCR technology. The company focuses on expanding molecular diagnostic accessibility across developing countries, particularly through primary healthcare facilities and mobile diagnostic networks.

F. Hoffmann-La Roche Ltd

Roche is a global healthcare company with extensive capabilities in molecular diagnostics, clinical laboratory automation, and infectious disease testing. Its diagnostic portfolio includes molecular testing platforms, reagents and laboratory solutions that support pathogen detection and disease surveillance. Through its international commercial infrastructure, Roche serves hospitals, reference laboratories and healthcare systems across developed and emerging markets.

Other key players in the market include Abbott, Becton, Dickinson and Company (BD), Cepheid, Eiken Chemical Co., Ltd., Thermo Fisher Scientific Inc., and Hain Lifescience GmbH.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Peru Tuberculosis Diagnostics Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Diagnostics

  • Molecular Diagnostics
  • Sputum Smear Microscopy
  • Culture-Based Diagnostics
  • Immunological and Antigen-Based Tests
  • Drug Susceptibility Testing

The market is characterized by increasing adoption of rapid molecular testing, particularly for early detection of Mycobacterium tuberculosis and drug-resistant strains. Government-led TB control initiatives, rising MDR-TB burden, and investments in laboratory infrastructure are strengthening demand for accurate, rapid and accessible diagnostic technologies.

Market Breakup by Disease Type

  • Pulmonary Tuberculosis Diagnostics
  • Extrapulmonary Tuberculosis Diagnostics
  • Latent Tuberculosis Diagnostics Infection

The market is driven by the substantial burden of pulmonary tuberculosis, increasing screening of high-risk populations, and the need for improved detection of extrapulmonary infections. Growing awareness of latent TB infection, particularly among household contacts, healthcare workers, and immunocompromised individuals, is further supporting demand for immunological testing and targeted diagnostic programmes.

Market Breakup by End User

  • Hospitals
  • Diagnostic Labs
  • Research Laboratories
  • Others

Hospitals represent important diagnostic centres owing to their patient volumes, access to clinical infrastructure, and capacity to conduct confirmatory testing. Demand from diagnostic laboratories is supported by the expansion of molecular testing networks, reference laboratory capabilities, and drug-resistance analysis, while research laboratories contribute through TB surveillance, epidemiological studies, and diagnostic technology development.

Key Questions Answered in the Peru Tuberculosis Diagnostics Market Report

  • What was the Peru tuberculosis diagnostics market value in 2025?
  • What is the Peru tuberculosis diagnostics market forecast outlook for 2026-2035?
  • What are the major factors aiding the Peru tuberculosis diagnostics market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major Peru tuberculosis diagnostics market trends?
  • Which diagnostics is expected to dominate the market segment?
  • Which disease type is projected to lead the market segment?
  • Which end user is anticipated to drive the market segment?
  • Who are the key players involved in the Peru tuberculosis diagnostics market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a structured research approach combining secondary research, market assessment, and data validation:

  • Primary Research: The market assessment considers relevant insights from tuberculosis diagnostic stakeholders, including healthcare providers, diagnostic laboratory professionals, procurement personnel, and public health experts, to evaluate diagnostic adoption, infrastructure requirements, and market challenges.
  • Secondary Research: The study uses information from Peru’s Ministry of Health (MINSA), the Global Fund, and Agencia Andina to assess government initiatives, diagnostic infrastructure expansion, and the deployment of portable molecular testing and AI-enabled X-ray systems. Company websites and product portfolios of Abbott, QIAGEN, FUJIFILM, Molbio Diagnostics, Roche, and other key players support the competitive and product landscape analysis.
  • Validation: Market estimates and qualitative findings are assessed through cross-verification of available sources and top-down and bottom-up market analysis to ensure consistency and reliability.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Diagnostics
  • Disease Type
  • End User
Breakup by Diagnostics
  • Molecular Diagnostics
  • Sputum Smear Microscopy
  • Culture-Based Diagnostics
  • Immunological & Antigen-Based Tests
  • Drug Susceptibility Testing
Breakup by Disease Type
  • Pulmonary Tuberculosis Diagnostics
  • Extrapulmonary Tuberculosis Diagnostics
  • Latent Tuberculosis Diagnostics Infection
Breakup by End User
  • Hospitals
  • Diagnostic Labs
  • Research Laboratories
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Abbott
  • Becton, Dickinson and Company (BD)
  • Qiagen N.V.
  • FUJIFILM Holdings Corporation
  • Cepheid
  • Molbio Diagnostics Private Limited
  • Hain Lifescience GmbH
  • Eiken Chemical Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.

Datasheet

10 % Off

USD

1,999

1,799

Single User License

10 % Off

USD

3,099

2,789

Five User License

15 % Off

USD

4,599

3,909

Corporate License

15 % Off

USD

5,999

5,099

Datasheet

One User

USD 1,999

USD 1,799

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 3,099

USD 2,789

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 4,599

USD 3,909

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 5,999

USD 5,099

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us